Recurrent Coronary Thrombus in a Patient With Chronic Immune Thrombocytopenia With Treatment Using Eltrombopag

Case Reports in Cardiology - Egypt
doi 10.1155/2019/2756319
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Tolerability and Efficacy of Eltrombopag in Chronic Immune Thrombocytopenia

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2016English

Relative Potency of the Thrombopoietin Receptor Agonists Eltrombopag, Avatrombopag and Romiplostim in a Patient With Chronic Immune Thrombocytopenia

British Journal of Haematology
Hematology
2018English

Eltrombopag-Based Combination Treatment for Immune Thrombocytopenia

Therapeutic Advances in Hematology
Hematology
2018English

An Alternative Intermittent Eltrombopag Dosing Protocol for Treatment of Chronic Immune Thrombocytopenia

British Journal of Clinical Pharmacology
Pharmacology
2018English

Thrombopoietin Level Predicts Response to Treatment With Eltrombopag and Romiplostim in Immune Thrombocytopenia

American Journal of Hematology
Hematology
2018English

A Patient With Recurrent Hypothermia Associated With Thrombocytopenia.

Postgraduate Medical Journal
Medicine
1993English

Therapy Induced Iron Deficiency in Children Treated With Eltrombopag for Immune Thrombocytopenia

American Journal of Hematology
Hematology
2017English

Primary Immune Thrombocytopenia Responding to Antithyroid Treatment in a Patient With Graves’ Disease

Annals of Hematology
MedicineHematology
2010English

Eltrombopag, a Thrombopoietin- Receptor Agonist in the Treatment of Adult Chronic Immune Thrombocytopenia: A Review of the Efficacy and Safety Profile

Therapeutic Advances in Hematology
Hematology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy